IP Library Granted Patent US 11,534,087
Granted Patent B2
US 11,534,087 · App. 16/989,291 · Granted Dec 27, 2022

Physiological measurement system with automatic wavelength adjustment

Inventors: Walter M. Weber (Laguna Hills, CA); Ammar Al-Ali (San Juan Capistrano, CA)
Assignee: CERCACOR LABORATORIES, INC.
A61B5/14551A61B5/0059A61B5/0205A61B5/7203A61B5/7221A61B5/0075
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,534,087
App. No.
16/989,291
Granted
Dec 27, 2022
Kind
B2
Abstract

Disclosed herein is a physiological measurement system that can automatically adjust the number of wavelengths used based on the quality of a sensor signal that is reflective of an optical radiation detected at a sensor after tissue attenuation. The signal quality is examined to determine if it is sufficient to support the use of a full set of wavelengths. If it is determined to be insufficient to support the full set, a reduced number of wavelengths is used.

Claims (32)

1. An optical non-invasive physiological parameter measurement system comprising:

one or more light emitting sources configured to emit light at a plurality of wavelengths;

a sensor configured to detect light emitted by the one or more light emitting sources after the emitted light is attenuated by body tissue, and to generate an output signal useable to measure at least one physiological parameter of the body tissue; and

a processor configured to:

cause the one or more light emitting sources to emit light at a first set of the plurality of wavelengths;

determine a confidence measurement value based on a first output signal received from the sensor based on detected light emitted at the first set of the plurality of wavelengths;

cause the one or more light emitting sources to emit light at a second set of the plurality of wavelengths by deactivating at least one of the plurality of wavelength emissions when the confidence measurement value is less than a threshold value; and

determine a physiological parameter measurement based on a second output signal received from the sensor based on detected light emitted at less than all of the plurality of wavelengths.

2. The system of claim 1 , wherein the confidence measurement is further determined based on a physiological data reference.

3. The system of claim 2 , wherein the physiological data reference comprises a normalized plethysmograph ratio region bounded by a high normalized plethysmograph ratio curve and a low normalized plethysmograph ratio curve.

4. The system of claim 3 , wherein the high normalized plethysmograph ratio curve is a high oxygen saturation (SpO 2 ) curve and the low normalized plethysmograph ratio curve is a low oxygen saturation (SpO 2 ) curve.

5. The system of claim 2 , wherein the physiological data reference comprises a reference parametric curve that is predetermined from clinically-derived data.

6. The system of claim 2 , wherein the physiological data reference comprises a data cluster defining a region of normalized plethysmograph values.

7. The system of claim 2 , wherein the second set of the plurality of wavelengths comprises two wavelengths.

8. The system of claim 7 , wherein one of the two wavelengths is in the red range and the other of the two wavelengths is in the infrared range.

9. The system of claim 1 , wherein the plurality of wavelengths comprises at least eight wavelengths.

10. The system of claim 1 , wherein the physiological parameter measurement comprises a SpO 2 , HbCO, HbMet, Hbt, factional oxygen saturation, bilirubin, or glucose measurement.

11. A method for automatically adjusting a number of a plurality of wavelengths used in a physiological measurement system, the method comprising:

emitting light at a first set of a plurality of wavelengths with one or more light emitting sources;

detecting, with a sensor, light emitted by one or more light emitting sources after attenuation by body tissue, the sensor generating a first output signal;

determining a confidence measurement value based on a first output signal received from the sensor based on the detected light emitted at the first set of the plurality of wavelengths;

deactivating at least one of the plurality of wavelength emissions when the confidence measurement value is less than a threshold value to cause the plurality of light emitting sources to emit light at a second set of the plurality of wavelengths; and

determining a physiological parameter measurement based on a second output signal received from the sensor based on the detected light emitted at the second set of the plurality of wavelengths.

12. The method of claim 11 , wherein determining the confidence measurement value is further based on a physiological data reference.

13. The method of claim 12 , wherein the physiological data reference comprises a normalized plethysmograph ratio region bounded by a high normalized plethysmograph ratio curve and a low normalized plethysmograph ratio curve.

14. The method of claim 13 , wherein the high normalized plethysmograph ratio curve is a high oxygen saturation (SpO 2 ) curve and the low normalized plethysmograph ratio curve is a low oxygen saturation (SpO 2 ) curve.

15. The method of claim 12 , wherein the physiological data reference comprises a reference parametric curve that is predetermined from clinically-derived data.

16. The method of claim 12 , wherein the physiological data reference comprises a data cluster defining a region of normalized plethysmograph values.

17. The method of claim 12 , wherein the second set of the plurality of wavelengths comprises two wavelengths.

18. The method of claim 17 , wherein one of the two wavelengths is in the red range and the other of the two wavelengths is in the infrared range.

19. The method of claim 11 , wherein the plurality of wavelengths comprises at least eight wavelengths.

20. The method of claim 11 , wherein the physiological parameter measurement comprises a SpO 2 , HbCO, HbMet, Hbt, factional oxygen saturation, bilirubin, or glucose measurement.

Assignments (4)
CHANGE OF NAME Recorded May 16, 2024
From: CERCACOR LABORATORIES, INC.
To: WILLOW LABORATORIES, INC.
Reel/Frame 067455/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2020
From: AL-ALI, AMMAR
To: CERCACOR LABORATORIES, INC.
Reel/Frame 053855/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2020
From: WEBER, WALTER M.
To: MASIMO LABORATORIES, INC.
Reel/Frame 053855/0251 →
CHANGE OF NAME Recorded Sep 23, 2020
From: MASIMO LABORATORIES, INC.
To: CERCACOR LABORATORIES, INC.
Reel/Frame 053855/0906 →
Continuity (5)
Continuation 15812930 · Nov 14, 2017
Continuation 12949271 · Nov 18, 2010
Provisional Application 61330253 · Apr 30, 2010
Provisional Application 61264182 · Nov 24, 2009
Related Publication 20200367796A1 · Nov 26, 2020
Cited By (2)
US 12,329,548 US 12,495,968